KRAS c.553_554delinsGC ;(p.C185A)

Variant ID: 12-25362742-CA-GC

NM_004985.3(KRAS):c.553_554delinsGC;(p.C185A)

This variant was identified in 5 publications

View GRCh38 version.




Publications:


AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis.

Nature Communications
Kim, Dae Gyu DG; Choi, Yongseok Y; Lee, Yuno Y; Lim, Semi S; Kong, Jiwon J; Song, JaeHa J; Roh, Younah Y; Harmalkar, Dipesh S DS; Lee, Kwanshik K; Goo, Ja-Il JI; Cho, Hye Young HY; Mushtaq, Ameeq Ul AU; Lee, Jihye J; Park, Song Hwa SH; Kim, Doyeun D; Min, Byung Soh BS; Lee, Kang Young KY; Jeon, Young Ho YH; Lee, Sunkyung S; Lee, Kyeong K; Kim, Sunghoon S
Publication Date: 2022-05-11

Variant appearance in text: KRAS: C185A
PubMed Link: 35546148
Variant Present in the following documents:
  • 41467_2022_30149_MOESM1_ESM.pdf
View BVdb publication page



Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.

Journal Of Medicinal Chemistry
Yelland, Tamas T; Garcia, Esther E; Parry, Charles C; Kowalczyk, Dominika D; Wojnowska, Marta M; Gohlke, Andrea A; Zalar, Matja M; Cameron, Kenneth K; Goodwin, Gillian G; Yu, Qing Q; Zhu, Peng-Cheng PC; ElMaghloob, Yasmin Y; Pugliese, Angelo A; Archibald, Lewis L; Jamieson, Andrew A; Chen, Yong Xiang YX; McArthur, Duncan D; Bower, Justin J; Ismail, Shehab S
Publication Date: 2022-02-01

Variant appearance in text: KRAS: C185A
PubMed Link: 35104933
Variant Present in the following documents:
  • Main text
  • jm1c01265_si_001.pdf
  • jm1c01265.pdf
View BVdb publication page



Stabilization of the RAS:PDE6D Complex Is a Novel Strategy to Inhibit RAS Signaling.

Journal Of Medicinal Chemistry
Yelland, Tamas T; Garcia, Esther E; Parry, Charles C; Kowalczyk, Dominika D; Wojnowska, Marta M; Gohlke, Andrea A; Zalar, Matja M; Cameron, Kenneth K; Goodwin, Gillian G; Yu, Qing Q; Zhu, Peng-Cheng PC; ElMaghloob, Yasmin Y; Pugliese, Angelo A; Archibald, Lewis L; Jamieson, Andrew A; Chen, Yong Xiang YX; McArthur, Duncan D; Bower, Justin J; Ismail, Shehab S
Publication Date: 2022-02-10

Variant appearance in text: KRAS: C185A
PubMed Link: 35104933
Variant Present in the following documents:
  • Main text
  • jm1c01265_si_001.pdf
  • jm1c01265.pdf
View BVdb publication page



Development of a High-throughput NanoBRET Screening Platform to Identify Modulators of the RAS/RAF Interaction.

Molecular Cancer Therapeutics
Durrant, David E DE; Smith, Emily A EA; Goncharova, Ekaterina I EI; Sharma, Nirmala N; Alexander, Patrick A PA; Stephen, Andrew G AG; Henrich, Curtis J CJ; Morrison, Deborah K DK
Publication Date: 2021-09

Variant appearance in text: KRAS: C185A
PubMed Link: 34158349
Variant Present in the following documents:
  • Main text
  • 1743.pdf
View BVdb publication page



Distinct Binding Preferences between Ras and Raf Family Members and the Impact on Oncogenic Ras Signaling.

Molecular Cell
Terrell, Elizabeth M EM; Durrant, David E DE; Ritt, Daniel A DA; Sealover, Nancy E NE; Sheffels, Erin E; Spencer-Smith, Russell R; Esposito, Dominic D; Zhou, Yong Y; Hancock, John F JF; Kortum, Robert L RL; Morrison, Deborah K DK
Publication Date: 2019-12-19

Variant appearance in text: K-Ras4B: C185A
PubMed Link: 31606273
Variant Present in the following documents:
  • Main text
View BVdb publication page



Farnesylation or geranylgeranylation? Efficient assays for testing protein prenylation in vitro and in vivo.

Bmc Biochemistry
Benetka, Wolfgang W; Koranda, Manfred M; Maurer-Stroh, Sebastian S; Pittner, Fritz F; Eisenhaber, Frank F
Publication Date: 2006-02-28

Variant appearance in text: K-Ras4B: C185A
PubMed Link: 16507103
Variant Present in the following documents:
  • Main text
  • 1471-2091-7-6.pdf
View BVdb publication page